Application Note

CE-SDS Analysis Of Etanercept Using The BioPhase 8800 System

By Zhichang Yang, Jane Luo, Marcia Santos, Sahana Mollah, SCIEX, USA

BioPhase 8800

Capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) is one of the most powerful separation techniques in the analytical chemistry toolbox because it offers a high speed of analysis, high resolution, and quantification. In this study, the BioPhase 8800 system was used to analyze etanercept by CE-SDS. The multi-capillary capability of the BioPhase 8800 system allowed for the simultaneous analysis of etanercept under different deglycosylation reaction conditions, deglycosylation time-course, and assessing the consistency of deglycosylation reactions in other lots, accelerating methods development for protein analysis.

Key features of the BioPhase 8800 System include:

  • Multi-capillary separation on the BioPhase 8800 system enables simultaneous analysis of multiple etanercept samples prepared under different conditions (reduction and deglycosylation)
  • Pre-assembled cartridge and ready to use CE-SDS kit and consumables simplifies operation
  • A time-course approach was used to help determine the optimal deglycosylation incubation periods for etanercept. The study indicates complete deglycosylation of etanercept was achieved within 1.5 hours.
  • The deglycosylation reaction conditions were applied to other lots to quickly evaluate the reaction consistency, made possible with the parallel processing capabilities of the BioPhase 8800 system, significantly shortening the overall analysis time
access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online